Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence
Safety and Efficacy of Hybrid Fractional Laser diVa Treatment for Symptoms of Urinary Incontinence
Sponsor: Sciton
This NA trial investigates Stress Urinary Incontinence and Urge Incontinence and is currently completed. Sciton leads this study, which shows 11 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Oct 2019 — Jan 2020 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
May 2019 — Oct 2019 [monthly]
Active Not Recruiting NA
-
Sep 2018 — May 2019 [monthly]
Active Not Recruiting NA
-
Jul 2018 — Sep 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jun 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sciton
For direct contact, visit the study record on ClinicalTrials.gov .